{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:52:31Z","timestamp":1773312751832,"version":"3.50.1"},"reference-count":67,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T00:00:00Z","timestamp":1485302400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009682","name":"Parkinson's NSW","doi-asserted-by":"publisher","award":["2257"],"award-info":[{"award-number":["2257"]}],"id":[{"id":"10.13039\/100009682","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Boyarsky Family"},{"name":"Stanley and John Roth"},{"name":"David and Helen Baffsky"},{"name":"Patricia A. Quick Foundation"},{"name":"David King"},{"name":"Doug Battersby"},{"name":"Iain S. Gray Foundation"},{"name":"FIVEX"},{"name":"Tony and Vivian Howland-Rose"},{"name":"Walter and Edith Sheldon"},{"name":"Gleneagle Securities"},{"name":"Geoffrey Towner"},{"name":"Amadeus Energy Ltd"},{"name":"Nick and Melanie Kell"},{"name":"J.O and J.R Wicking Trust"},{"name":"The Mason Foundation"},{"DOI":"10.13039\/501100001240","name":"SpinalCure Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001240","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0167211","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T18:50:32Z","timestamp":1485370232000},"page":"e0167211","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Activin A Inhibits MPTP and LPS-Induced Increases in Inflammatory Cell Populations and Loss of Dopamine Neurons in the Mouse Midbrain In Vivo"],"prefix":"10.1371","volume":"12","author":[{"given":"Sandy","family":"Stayte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Rentsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R.","family":"Tr\u00f6scher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Bamberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kong M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce","family":"Vissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0301-0082(98)00057-4","article-title":"Activity and injury-dependent expression of inducible transcription factors, growth factors and apoptosis-related genes within the central nervous system","volume":"57","author":"PE Hughes","year":"1999","journal-title":"Prog Neurobiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mds.25344","article-title":"Trophic factor gene therapy for Parkinson&apos;s disease","volume":"28","author":"JH Kordower","year":"2013","journal-title":"Mov Disord"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/77548","article-title":"Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo","volume":"6","author":"YP Tretter","year":"2000","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/j.1460-2075.1995.tb07052.x","article-title":"TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity","volume":"14","author":"K Krieglstein","year":"1995","journal-title":"EMBO J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1471-4159.2007.04785.x","article-title":"The neuroprotective effect of Activin A and B: implication for neurodegenerative diseases","volume":"103","author":"L Kupershmidt","year":"2007","journal-title":"J Neurochem"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e0124325","DOI":"10.1371\/journal.pone.0124325","article-title":"Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson&apos;s disease","volume":"10","author":"S Stayte","year":"2015","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/cddis.2011.17","article-title":"IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson&apos;s disease","volume":"2","author":"C Barcia","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuroscience.2012.02.004","article-title":"Long-term polarization of microglia upon alpha-synuclein overexpression in nonhuman primates","volume":"208","author":"P Barkholt","year":"2012","journal-title":"Neuroscience"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression","volume":"29","author":"HM Gao","year":"2008","journal-title":"Trends Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","article-title":"Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson&apos;s disease","volume":"5","author":"V Sanchez-Guajardo","year":"2010","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00441-010-1061-x","article-title":"Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytes","volume":"342","author":"B Wachter","year":"2011","journal-title":"Cell Tissue Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1097\/00001756-199710200-00023","article-title":"Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli","volume":"8","author":"E Appel","year":"1997","journal-title":"Neuroreport"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuroscience.2015.07.014","article-title":"GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson&apos;s disease","volume":"303","author":"DB Hoban","year":"2015","journal-title":"Neuroscience"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson&apos;s disease","volume":"270","author":"M Mogi","year":"1999","journal-title":"Neurosci Lett"},{"key":"ref15","first-page":"37","article-title":"Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators","volume":"10","author":"HS Suh","year":"2013","journal-title":"J Neuroinflammation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/stem.80","article-title":"Activin A is essential for neurogenesis following neurodegeneration","volume":"27","author":"A Abdipranoto-Cowley","year":"2009","journal-title":"Stem Cells"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"HJ Gundersen","year":"1987","journal-title":"J Microsc"},{"key":"ref18","unstructured":"Paxinos G, Franklin K (2001) The mouse brain in stereotaxic coordinates. San Diego: Academic Press."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.410360213","article-title":"Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys: effect of levodopa and GM1 ganglioside therapy","volume":"36","author":"A Kastner","year":"1994","journal-title":"Ann Neurol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.03.028","article-title":"Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism","volume":"340","author":"EA Kozina","year":"2014","journal-title":"J Neurol Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/syn.20089","article-title":"Selective alterations of gene expression in mice induced by MPTP","volume":"55","author":"Z Xu","year":"2005","journal-title":"Synapse"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"JM Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","article-title":"Mechanisms of dopamine transporter regulation in normal and disease states","volume":"34","author":"RA Vaughan","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0149-7634(00)00028-2","article-title":"The role of the locus coeruleus in the development of Parkinson&apos;s disease","volume":"24","author":"M Gesi","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","article-title":"Norepinephrine: The redheaded stepchild of Parkinson&apos;s disease","volume":"74","author":"KS Rommelfanger","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"PR Dunkley","year":"2004","journal-title":"J Neurochem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson&apos;s disease","volume":"21","author":"E Bezard","year":"2001","journal-title":"J Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1046\/j.1460-9568.1999.00764.x","article-title":"Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter","volume":"11","author":"M Jaber","year":"1999","journal-title":"Eur J Neurosci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","article-title":"Profound neuronal plasticity in response to inactivation of the dopamine transporter","volume":"95","author":"SR Jones","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(84)90521-1","article-title":"Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse","volume":"97","author":"H Hallman","year":"1984","journal-title":"Eur J Pharmacol"},{"issue":"Suppl","key":"ref31","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1016\/0197-0186(92)90256-Q","article-title":"The MPTP-treated mouse as a model of parkinsonism: how good is it","volume":"20","author":"RE Heikkila","year":"1992","journal-title":"Neurochem Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0006-8993(87)90033-3","article-title":"Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice","volume":"402","author":"GL Willis","year":"1987","journal-title":"Brain Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2001.00397.x","article-title":"Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson&apos;s disease using cDNA microarray: effect of R-apomorphine","volume":"78","author":"E Grunblatt","year":"2001","journal-title":"J Neurochem"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"PL McGeer","year":"2003","journal-title":"Ann Neurol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2008.08.003","article-title":"The effects of MPTP on the activation of microglia\/astrocytes and cytokine\/chemokine levels in different mice strains","volume":"204","author":"Y Yasuda","year":"2008","journal-title":"J Neuroimmunol"},{"key":"ref36","article-title":"Following Complete Review of Phase 2 Trial Data Amgen Confirms Decision to Halt GDNF Study; Comprehensive Review of Scientific Findings, Patient Safety, Drove Decision","year":"2005"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182904faa","article-title":"Safety\/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients","volume":"80","author":"RT Bartus","year":"2013","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/mds.23442","article-title":"Bioactivity of AAV2-neurturin gene therapy (CERE-120): differences between Parkinson&apos;s disease and nonhuman primate brains","volume":"26","author":"RT Bartus","year":"2011","journal-title":"Mov Disord"},{"key":"ref39","unstructured":"Ceregene (2013) Ceregene reports data from Parkinson&apos;s disease Phase 2b study. San Diego."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q","article-title":"Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson&apos;s disease","volume":"46","author":"JH Kordower","year":"1999","journal-title":"Ann Neurol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time-Course and Morphology of Dopaminergic Neuronal Death Caused by the Neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine","volume":"4","author":"V Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0304-3940(02)00704-8","article-title":"Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra","volume":"329","author":"ZH Feng","year":"2002","journal-title":"Neurosci Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-005-0402-5","article-title":"Influence of noradrenaline denervation on MPTP-induced deficits in mice","volume":"113","author":"T Archer","year":"2006","journal-title":"J Neural Transm"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-3565(24)37011-9","article-title":"Effects of noradrenergic lesions on MPTP\/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions","volume":"283","author":"F Fornai","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0306-4522(00)00385-7","article-title":"Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons","volume":"101","author":"DC German","year":"2000","journal-title":"Neuroscience"},{"key":"ref46","first-page":"166","article-title":"Movement Disorders 2","author":"Y Agid","year":"1987"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/sj.bjp.0702943","article-title":"The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat","volume":"128","author":"MP Hill","year":"1999","journal-title":"Br J Pharmacol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pbb.2011.09.009","article-title":"Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by alpha- and beta-adrenergic receptor antagonists in hemiparkinsonian rats","volume":"100","author":"CJ Barnum","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson&apos;s disease","volume":"151","author":"B Henry","year":"1998","journal-title":"Exp Neurol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"J Meiser","year":"2013","journal-title":"Cell Commun Signal"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson&apos;s disease","volume":"125","author":"M Sedelis","year":"2001","journal-title":"Behav Brain Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/hum.2008.201","article-title":"Functional effects of AAV2-GDNF on the dopaminergic nigrostriatal pathway in parkinsonian rhesus monkeys","volume":"20","author":"JL Eberling","year":"2009","journal-title":"Hum Gene Ther"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.expneurol.2003.08.007","article-title":"Recombinant adeno-associated viral vector (rAAV) delivery of GDNF provides protection against 6-OHDA lesion in the common marmoset monkey (Callithrix jacchus)","volume":"184","author":"A Eslamboli","year":"2003","journal-title":"Exp Neurol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2013.04.011","article-title":"Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120)","volume":"58","author":"CD Herzog","year":"2013","journal-title":"Neurobiol Dis"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/hum.2008.137","article-title":"Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys","volume":"20","author":"LC Johnston","year":"2009","journal-title":"Hum Gene Ther"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1046\/j.1460-9568.2000.00274.x","article-title":"Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor","volume":"12","author":"D Kirik","year":"2000","journal-title":"Eur J Neurosci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.gt.3301682","article-title":"Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson&apos;s disease","volume":"9","author":"L Wang","year":"2002","journal-title":"Gene Ther"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/neur.1996.0020","article-title":"Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson&apos;s disease mice model","volume":"5","author":"A Czlonkowska","year":"1996","journal-title":"Neurodegeneration"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","article-title":"Microglial and astrocytic involvement in a murine model of Parkinson&apos;s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"M Kohutnicka","year":"1998","journal-title":"Immunopharmacology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/cne.21014","article-title":"Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57\/Bl mice","volume":"497","author":"LW Chen","year":"2006","journal-title":"J Comp Neurol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson&apos;s disease: Critical role for the astrocyte","volume":"106","author":"PC Chen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1046\/j.1471-4159.1998.70041584.x","article-title":"Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system","volume":"70","author":"A Castano","year":"1998","journal-title":"J Neurochem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1995.tb20368.x","article-title":"Activin A and retinoic acid synergize in cyclooxygenase-1 and thromboxane synthase induction during differentiation of J774.1 macrophages","volume":"227","author":"RM Nusing","year":"1995","journal-title":"Eur J Biochem"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/321776a0","article-title":"Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid","volume":"321","author":"W Vale","year":"1986","journal-title":"Nature"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cyto.2008.01.010","article-title":"Inhibitory effect of activin A on activation of lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells","volume":"42","author":"SY Wang","year":"2008","journal-title":"Cytokine"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbrc.2013.04.077","article-title":"Activin A inhibits activities of lipopolysaccharide-activated macrophages via TLR4, not of TLR2","volume":"435","author":"N Li","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00429-012-0446-x","article-title":"Differential distribution and activation of microglia in the brain of male C57BL\/6J mice","volume":"218","author":"TT Yang","year":"2013","journal-title":"Brain Struct Funct"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0167211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T19:56:59Z","timestamp":1749931019000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0167211"}},"subtitle":[],"editor":[{"given":"Joohyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,25]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0167211","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,25]]}}}